Natural Biocon postpones its board meeting from April 30 to May 9, 2026, for approving audited financial results.
The meeting was originally scheduled to consider Q4 and FY26 results with auditor's report and certificate.
This intimation is made pursuant to SEBI Listing Regulations, specifically Regulation 29.
The signed communication is from Managing Director Arunkumar Prajapati (DIN: 08281232).